Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...
Researchers from the National University of Singapore (NUS) have developed a "capping-and-coupling" strategy to transform naturally occurring (native) sugars directly into compounds known as ...
Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...
The merger process reached its formal conclusion on January 6, 2026, with Mainz-based BioNTech SE becoming the sole owner. The operational entity, CureVac Merger B.V., has replaced the original ...
AZoLifeSciences on MSN
Single enzyme enables low-cost synthesis of all RNA nucleotides
A single enzyme that can generate all four nucleotide triphosphates, the building blocks of ribonucleic acid (RNA), was ...
The companies plan a comprehensive analytical characterization to confirm that the m¹ΨTP produced by this new process meets stringent commercial-quality specifications for purity, safety, and ...
What just happened? TSMC has begun volume production of chips based on its N2 process technology, marking a major new step in 2nm-class node manufacturing. The company disclosed the milestone on its ...
Nearly a decade after Judy Hopps and Nick Wilde first hit the big screen, the team behind Zootopia has returned to the mammal metropolis with Zootopia 2, and they are very aware of how much these ...
RNA-based therapeutics are transforming medicine, but scaling production efficiently remains a challenge, particularly the cost-intensive in vitro transcription (IVT) step. Join this webinar to ...
With a $140 million investment, Moderna will bring its drug product manufacturing to the United States, joining a parade of drugmakers looking to strengthen their supply chains and reduce exposure to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results